181 related articles for article (PubMed ID: 20371960)
21. Thrombotic thrombocytopenic purpura associated with pegylated-interferon alpha-2a by an ADAMTS13 inhibitor in a patient with chronic hepatitis C.
Kitano K; Gibo Y; Kamijo A; Furuta K; Oguchi S; Joshita S; Takahashi Y; Ishida F; Matsumoto M; Uemura M; Fujimura Y
Haematologica; 2006 Aug; 91(8 Suppl):ECR34. PubMed ID: 16923518
[TBL] [Abstract][Full Text] [Related]
22. Influenza-associated thrombotic microangiopathies.
Bitzan M; Zieg J
Pediatr Nephrol; 2018 Nov; 33(11):2009-2025. PubMed ID: 28884355
[TBL] [Abstract][Full Text] [Related]
23. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma.
Isonishi A; Bennett CL; Plaimauer B; Scheiflinger F; Matsumoto M; Fujimura Y
Transfusion; 2015 Oct; 55(10):2321-30. PubMed ID: 26058519
[TBL] [Abstract][Full Text] [Related]
24. Inverse correlation of free and immune complex-sequestered anti-ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Knöbl P; Kolovratova V; Plaimauer B; Turecek PL; Varadi K; Rottensteiner H; Scheiflinger F
J Thromb Haemost; 2012 Jan; 10(1):156-8. PubMed ID: 22044668
[No Abstract] [Full Text] [Related]
25. Seasonal distribution of severe ADAMTS13 deficient idiopathic thrombotic thrombocytopenic purpura.
Raval JS; Harm SK; Rollins-Raval MA; Kiss JE
J Clin Apher; 2014 Apr; 29(2):113-9. PubMed ID: 24123112
[TBL] [Abstract][Full Text] [Related]
26. Thrombotic thrombocytopenic purpura due to anti-ADAMTS13 antibodies in multiple myeloma.
Yao H; Monge M; Renou M; Lecaque C; Jauréguy M; Presne C; Makdassi R; Choukroun G
Clin Nephrol; 2014 Mar; 81(3):210-5. PubMed ID: 23073062
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity.
Cataland SR; Jin M; Lin S; Kennedy MS; Kraut EH; George JN; Wu HM
Br J Haematol; 2007 Nov; 139(3):486-93. PubMed ID: 17910638
[TBL] [Abstract][Full Text] [Related]
28. A case of mixed connective tissue disease complicated with thrombotic thrombocytopenic purpura.
Kuroda T; Matsuyama K; Nakatsue T; Murakami S; Hasegawa H; Nakayama H; Sakatsume M; Ueno M; Nakano M; Gejyo F
Clin Rheumatol; 2007 Jan; 26(1):101-4. PubMed ID: 16391894
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
Duraković N; Radonić R; Gasparović V
Coll Antropol; 2010 Sep; 34(3):1087-91. PubMed ID: 20977108
[TBL] [Abstract][Full Text] [Related]
30. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
[TBL] [Abstract][Full Text] [Related]
31. Thrombotic thrombocytopenic purpura: a moving target.
Sadler JE
Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
[TBL] [Abstract][Full Text] [Related]
32. [Very severe thrombotic thrombocytopenic purpura (TTP) after H1N1 vaccination].
Hermann R; Pfeil A; Busch M; Kettner C; Kretzschmar D; Hansch A; La Rosée P; Wolf G
Med Klin (Munich); 2010 Sep; 105(9):663-8. PubMed ID: 20878304
[TBL] [Abstract][Full Text] [Related]
33. Current management of thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Meyer SC
Curr Opin Hematol; 2008 Sep; 15(5):445-50. PubMed ID: 18695366
[TBL] [Abstract][Full Text] [Related]
34. Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse.
Jin M; Casper TC; Cataland SR; Kennedy MS; Lin S; Li YJ; Wu HM
Br J Haematol; 2008 May; 141(5):651-8. PubMed ID: 18397340
[TBL] [Abstract][Full Text] [Related]
35. The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura.
Luken BM; Turenhout EA; Hulstein JJ; Van Mourik JA; Fijnheer R; Voorberg J
Thromb Haemost; 2005 Feb; 93(2):267-74. PubMed ID: 15711742
[TBL] [Abstract][Full Text] [Related]
36. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S
Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
[TBL] [Abstract][Full Text] [Related]
37. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
[TBL] [Abstract][Full Text] [Related]
38. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
[TBL] [Abstract][Full Text] [Related]
39. Two cases of refractory thrombotic thrombocytopenic purpura associated with collagen vascular disease were significantly improved by rituximab treatment.
Kameda T; Dobashi H; Kittaka K; Susaki K; Yamaoka G; Arai K; Tokuda M; Ishida T
Clin Rheumatol; 2007 Dec; 26(12):2159-2162. PubMed ID: 17562094
[TBL] [Abstract][Full Text] [Related]
40. [Determination of the ADAMTS13 antigen and its activity in TTP patients and carriers].
Liu F; Feys HB; Dong NZ; Bai X; Vanhoorelbeke K; Deckmyn H; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):154-7. PubMed ID: 16792913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
